Latest Share Based Payments News

BSA Limited’s FY26 results reveal a dramatic 89% plunge in revenue following the loss of the nbn contract, yet profit after tax rose 14% to $4.27 million as the company restructured and secured a key Foxtel contract extension.

Cleo Diagnostics (ASX:COV) posted a 48% jump in annual loss to $5.9 million amid key progress in its ovarian cancer diagnostic test, including completion of a pivotal US trial and preparations for FDA 510(k) submission.

PlaySide Studios reversed a prior-year loss with a 13% revenue increase to $54.9 million and a 144% jump in net profit to $5.4 million, driven by strong Original IP sales and a strategic cost restructure.

Percheron Therapeutics reduced its FY2026 loss to $4.79 million as it prepares to launch a pivotal phase II trial for its immuno-oncology drug HMBD-002, while managing a CEO transition and tightening cash reserves.

Audinate Group Limited reported a 15% revenue increase driven by its expanding Dante ecosystem and Iris acquisition, but underlying EBITDA losses widened amid restructuring and investment costs.

Tarrina Resources (ASX:TR8) posted a $3.63 million loss for FY2026 as it ramped up exploration at its newly acquired gold and base metal projects following a $5 million capital raise and ASX relisting.

Microequities Asset Management Group saw a 20.1% drop in profit after tax for FY26, hit by sharp valuation falls in tech-heavy portfolios amid AI fears, despite a 1.5% revenue rise and a strong balance sheet.

Black Horse Mining Limited completed an $8 million IPO and acquired an 80% stake in the Mt Egerton Gold Project holder. The company reported a $5.87 million loss for FY26, driven by exploration costs and significant share-based payments.

Infinity Metals has locked in an exclusive option to acquire 100% of the Tule Canyon molybdenum-copper project in Nevada, a historically explored porphyry deposit with promising drill results and strategic positioning amid soaring molybdenum prices.

Verbrec Limited confirms a robust FY2026 with revenues up nearly 50%, while unveiling a bullish FY2027 outlook driven by full-year Alliance Automation integration and expanding project pipelines.

Neu Horizon Uranium Limited, formerly Tasmania Data Infrastructure, has pivoted from bitcoin mining to uranium exploration in Sweden, reporting a reduced loss for FY25 while progressing towards an ASX listing and expanding its footprint into Canadian mineral claims.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.